Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome-Reference-Cited by-同舟云学术

Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome

Published:2016-03 Issue:3 Volume:89 Page:701-711
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Greenbaum Larry A.,Fila Marc,Ardissino Gianluigi,Al-Akash Samhar I.,Evans Jonathan,Henning Paul,Lieberman Kenneth V.,Maringhini Silvio,Pape Lars,Rees Lesley,van de Kar Nicole C.A.J.,Vande Walle Johan,Ogawa Masayo,Bedrosian Camille L.,Licht Christoph

Publisher

Elsevier BV

Subject

Nephrology

Reference52 articles.

1. Atypical hemolytic–uremic syndrome;Noris;N Engl J Med,2009

2. Thrombotic microangiopathies: new insights and new challenges;Zipfel;Curr Opin Nephrol Hypertens,2010

3. Thrombotic microangiopathy: new insights;Benz;Curr Opin Nephrol Hypertens,2010

4. Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype;Noris;Clin J Am Soc Nephrol,2010

5. Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults;Fremeaux–Bacchi;Clin J Am Soc Nephrol,2013

Cited by 227 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Complement system activation: bridging physiology, pathophysiology, and therapy;Intensive Care Medicine;2024-09-10

2. The efficacy and safety of eculizumab in patients and the role of C5 polymorphisms;Drug Discovery Today;2024-09

3. Characterizing the association between complement-mediated TMA and cognitive dysfunction using MRI and neurocognitive assessment;Blood Vessels, Thrombosis & Hemostasis;2024-09

4. Ravulizumab in Atypical Hemolytic Uremic Syndrome: An Analysis of 2-Year Efficacy and Safety Outcomes in 2 Phase 3 Trials;Kidney Medicine;2024-08

5. Recurrent complement-mediated Hemolytic uremic syndrome after kidney transplantation;Transplantation Reviews;2024-07